PALASIS MARIA (President & CEO) reported 1 transaction at LYRA THERAPEUTICS, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 4/3/2026ACC: 0001193125-26-142100
DirectorOfficer· President & CEO
Since Apr 2020
-2K
Net shares
Net seller
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
2K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−2K
Price / share
—
Trade value
—
% of position
0.2%
4/1/2026
1.10M→1.09M
Total
Net shares
−2K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 4/1/2026 | D · Disposition | −2K | — | — | 0.2% | 1.10M | 1.09M |
| Total | −2K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported